Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Archive
 
May 1993, Volume 11 No 5
The First Word
CorrespondenceErrata
Commentary
News Analysis
Articles
Review
Research
Book Review
Biotools
Bio Q&A
Fermentors
Reader ServiceNew Products
The Last Word
ISSUE
The First Word Top
Blues p531
Douglas K. McCormick
doi:10.1038/nbt0593-531
PDF (114K)
Correspondence Top
Headline Outrage p532
Margaret D. Rosa
doi:10.1038/nbt0593-532a
PDF (88K)
Elephants in the Living Room p532
William F. Schraeder
doi:10.1038/nbt0593-532b
PDF (88K)
Pasteur's Place p532
Alfred Hemming
doi:10.1038/nbt0593-532c
PDF (88K)
Agbio Not the Problem p532
Peter Marketos
doi:10.1038/nbt0593-532d
PDF (88K)
Anniversary Greetings p532
David L. Poole
doi:10.1038/nbt0593-532e
PDF (88K)
Errata
Errata p532
doi:10.1038/nbt0593-532f
PDF (88K)
Commentary Top
The Strange Case of the Pitter p535
Bernard Dixon
doi:10.1038/nbt0593-535
PDF (108K)
News Analysis Top
Clinton seeks $4.3 billion for biotech R&D p536
Jeffrey L. Fox
doi:10.1038/nbt0593-536
PDF (105K)
FDA advisory panel okays beta interferon for MS pp538 - 539
Jeffrey L. Fox
doi:10.1038/nbt0593-538
PDF (237K)
Centocor's CentoRx benefits risky angioplasty p539
B. J. Spalding
doi:10.1038/nbt0593-539
PDF (122K)
Does Gensia's Arasine help heart patients? p541
B. J. Spalding
doi:10.1038/nbt0593-541
PDF (128K)
Firms should pursue narrow indications p542
Paul Abrams
doi:10.1038/nbt0593-542
PDF (134K)
Drug price controls will stunt biotech's growth pp544 - 545
Jeffrey Casdin
doi:10.1038/nbt0593-544
PDF (228K)
Public-firm execs get $116,000 p545
B. J. Spalding
doi:10.1038/nbt0593-545
PDF (116K)
First quarter sees 27 firms raise $649.7 million p548
B. J. Spalding
doi:10.1038/nbt0593-548
PDF (105K)
Shaman's $45 million IPO is quarter's biggest p549
Mark Goodstein
doi:10.1038/nbt0593-549a
PDF (122K)
Latvian biotech firm busted for selling speed p549
Gerard O'Dwyer
doi:10.1038/nbt0593-549b
PDF (122K)
European trade associations move to consolidate p551
Mike Ward
doi:10.1038/nbt0593-551
PDF (126K)
Improved animal feed may be just "chicken feed" p552
George Kidd
doi:10.1038/nbt0593-552
PDF (131K)
15 agbiotech firms lost $126.4 million last year p554
B. J. Spalding
doi:10.1038/nbt0593-554a
PDF (88K)
FDA advisory panel mooooves Monsanto's BST pp554 - 555
Jeffrey L. Fox
doi:10.1038/nbt0593-554b
PDF (202K)
CLIA '88 lab regulations are watered down p556
Joseph Alper
doi:10.1038/nbt0593-556
PDF (242K)
Vague shape of Clinton's biotech policy emerges pp558 - 559
Russ Hoyle
doi:10.1038/nbt0593-558
PDF (277K)
Articles Top
Multiuse Biopharmaceutical Manufacturing pp561 - 570
Mic N. Hamers
doi:10.1038/nbt0593-561
Abstract + references | PDF (833K)
Flow Cytometry in Animal Cell Culture pp572 - 579
Mohamed Al-Rubeai & A. Nicholas Emery
doi:10.1038/nbt0593-572
Abstract + references | PDF (612K)
Nuclease Therapeutics in the Clinic pp580 - 582
Stephen M. Edgington
doi:10.1038/nbt0593-580
Abstract + references | PDF (359K)
Review Top
Molecular Analysis of Small Grain Cereal Genomes: Current Status and Prospects pp584 - 589
Graham Moore, Michael D. Gale, Nori Kurata & Richard B. Flavell
doi:10.1038/nbt0593-584
Abstract + references | PDF (813K)
Research Top
Efficient Production of Antibody Fragments by the Filamentous Fungus Trichoderma reesei pp591 - 595
Eini Nyyssönen, Merja Penttilä, Anu Harkki, Anu Saloheimo, Jonathan K. C. Knowles & Sirkka Keränen
doi:10.1038/nbt0593-591
Abstract + references | PDF (815K)
Transformation of Elite Cotton Cultivars via Particle Bombardment of Meristems pp596 - 598
Dennis E. McCabe & Brian J. Martinell
doi:10.1038/nbt0593-596
Abstract + references | PDF (459K)
Recombinant Colorimetric Antibodies: Construction and Characterization of a Bifunctional F(ab)2/Alkaline Phosphatase Conjugate Produced in Escherichia coli pp601 - 605
Frédéric Ducancel, Daniel Gillet, Alice Carrier, Evelyne Lajeunesse, André Ménez & Jean-Claude Boulain
doi:10.1038/nbt0593-601
Abstract + references | PDF (869K)
Conversion of Starch to Ethanol in a Recombinant Saccharomyces cerevisiae Strain Expressing Rice alpha-Amylase from a Novel Pichia pastoris Alcohol Oxidase Promoter pp606 - 610
Monto H. Kumagai, Genadie G. Sverlow, Guy della-Cioppa & Laurence K. Grill
doi:10.1038/nbt0593-606
Abstract + references | PDF (963K)
Efficient Bacterial Export of a Eukaryotic Cytoplasmic Cytochrome pp612 - 618
Amna Karim, Naheed Kaderbhai, Alun Evans, Victoria Harding & Mustak A. Kaderbhai
doi:10.1038/nbt0593-612
Abstract + references | PDF (1,284K)
Book Review Top
The Driving Forces of Biotechnology pp620 - 621
Jan A. Witkowski
doi:10.1038/nbt0593-620
PDF (363K)
Biotools Top
BioBOSS: A Bioprocessing Software Tool pp622 - 623
Terhi Siimes, Marjut Pokkinen, Andrea Holmberg & Pekka Linko
doi:10.1038/nbt0593-622
References | PDF (325K)
Ribozymes' Patent History pp624 - 625
Stephen M. Edgington
doi:10.1038/nbt0593-624
PDF (360K)
Bio Q&A Top
Fermentation and Cell Culture p626
John Hodgson
doi:10.1038/nbt0593-626
PDF (101K)
Fermentors Top
Fermentors p628
doi:10.1038/nbt0593-628
PDF (168K)
Reader Service Top
New Products
New Products pp629 - 630
doi:10.1038/nbt0593-629
PDF (290K)
The Last Word Top
A Word or Two from the Wise p636
John Hodgson
doi:10.1038/nbt0593-636
PDF (101K)
  Top
 
ADVERTISEMENT
Register-TOCRegister for table of contents e-alerts
RecommendRecommend to your library
ReceiveReceive news feeds
what is a news feed?
Nature Biotechnology in the news
Impact factor

Open Innovation Challenges

natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works ©1998 - 2006 Nature Publishing Group | Privacy policy